Valuing ResApp Health, page-179

Thanks! In my opinion I'm leaning towards option 1 but I still don't think it's going to entice us enough to sell out even if option one plays out and the bid goes as high as 20 or 30 cents! I'd be happy to see option 3 play out.

Option 3 would be in the best interests of shareholders. Let's say Pfizer come to the realisation that no matter what price they throw at us shareholders will not surrender. They're willing to pay us 100 million in cash. So surely they have just as much to throw at us for a commercial partnership agreement even if it was for just a quarter of that. The share price would surge on the back of that, well above 11.5 IMO!

Cheers

Red bar